Skip to main content
. 2022 Jun 30;15:17562848221105976. doi: 10.1177/17562848221105976

Figure 1.

Figure 1.

Effectiveness analysis. (a) Proportion of patients without the requirement of platelet transfusion or any treatment for bleeding. (b) Proportion of patients with platelet count ⩾50 × 109/L on the day of examination or operation.

Source: NCT01972529 and NCT01976104 clinical studies.

n, proportion of responders; N, total population; difference of percentage, avatrombopag 40 or 60 mg compared with placebo; p values were based on the Cochran–Mantel–Haenszel test (which was stratified by the risk of bleeding associated with planned surgery).